Home › Aortic Valve Stenosis › Kansas › Wichita
Aortic Valve Stenosis clinical trials in Wichita, KS
5 studies for Aortic Valve Stenosis are looking for participants at sites in and around Wichita (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve
Recruiting
- Ascension Via Christi St. Francis (Cardiovascular Research Institute of Kansas), Wichita
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
RecruitingObservational study
- Ascension Via Christi St. Francis, Wichita
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
Recruiting
- Cardiovascular Research Institute of Kansas, Wichita
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Recruiting
- Ascension Via Christi St. Francis, Wichita
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Recruiting
- Cardiovascular Research Institute of Kansas, Wichita
Aortic Valve Stenosis trials in other cities
- Boston, MA10 studies
- San Francisco, CA9 studies
- New York City, NY9 studies
- Cleveland, OH8 studies
- Cincinnati, OH7 studies
- Houston, TX7 studies
- Mountain View, CA7 studies
- Rochester, MN6 studies
- Detroit, MI6 studies
- Chicago, IL6 studies
- Pittsburgh, PA6 studies
- Nashville, TN6 studies
Other studies in Wichita
- Obesity11 studies
- Type 2 Diabetes10 studies
- Heart Failure8 studies
- High Blood Pressure8 studies
- Overweight8 studies
- Coronary Artery Disease7 studies
- Non-Small Cell Lung Cancer5 studies
- Lung Cancer5 studies
- Breast Cancer5 studies
- Cardiovascular Disease4 studies
- Colorectal Cancer4 studies
- Huntington's Disease3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.